Financial giants have made a conspicuous bearish move on Johnson & Johnson. Our analysis of options history for Johnson & Johnson JNJ revealed 10 unusual trades.
Delving into the details, we found 40% of traders were bullish, while 60% showed bearish tendencies. Out of all the trades we spotted, 6 were puts, with a value of $853,255, and 4 were calls, valued at $192,155.
What's The Price Target?
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $150.0 to $200.0 for Johnson & Johnson over the recent three months.
Volume & Open Interest Development
In terms of liquidity and interest, the mean open interest for Johnson & Johnson options trades today is 3097.78 with a total volume of 563.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Johnson & Johnson's big money trades within a strike price range of $150.0 to $200.0 over the last 30 days.
Johnson & Johnson Option Volume And Open Interest Over Last 30 Days
Biggest Options Spotted:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|
| JNJ | PUT | TRADE | BEARISH | 11/24/23 | $170.00 | $576.0K | 60 | 0 |
| JNJ | PUT | TRADE | BEARISH | 01/19/24 | $160.00 | $93.1K | 6.0K | 229 |
| JNJ | CALL | TRADE | BULLISH | 01/19/24 | $155.00 | $84.0K | 7.1K | 95 |
| JNJ | PUT | SWEEP | BEARISH | 06/21/24 | $160.00 | $74.3K | 3.2K | 0 |
| JNJ | PUT | TRADE | BEARISH | 01/19/24 | $155.00 | $52.5K | 6.9K | 3 |
About Johnson & Johnson
Johnson & Johnson is the world's largest and most diverse healthcare firm. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women's health. The consumer group is being divested in 2023 under the new name Kenvue. Geographically, just over half of total revenue is generated in the United States.
In light of the recent options history for Johnson & Johnson, it's now appropriate to focus on the company itself. We aim to explore its current performance.
Where Is Johnson & Johnson Standing Right Now?
- Currently trading with a volume of 2,486,687, the JNJ's price is up by 0.25%, now at $151.5.
- RSI readings suggest the stock is currently is currently neutral between overbought and oversold.
- Anticipated earnings release is in 62 days.
What The Experts Say On Johnson & Johnson
In the last month, 2 experts released ratings on this stock with an average target price of $215.0.
- An analyst from Cantor Fitzgerald downgraded its action to Overweight with a price target of $215.
- In a cautious move, an analyst from Cantor Fitzgerald downgraded its rating to Overweight, setting a price target of $215.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Johnson & Johnson, Benzinga Pro gives you real-time options trades alerts.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
